4//SEC Filing
Anacor Pharmaceuticals, Inc. 4
Accession 0001209191-15-043018
CIK 0001411158operating
Filed
May 13, 8:00 PM ET
Accepted
May 14, 9:12 PM ET
Size
10.4 KB
Accession
0001209191-15-043018
Insider Transaction Report
Form 4
Maples Kirk R
Senior VP Program Mgt
Transactions
- Exercise/Conversion
Common Stock
2015-05-12$6.92/sh+6,060$41,935→ 13,880 total - Sale
Common Stock
2015-05-12$60.97/sh−4,900$298,751→ 8,980 total - Exercise/Conversion
Stock Option (right to buy)
2015-05-12−6,060→ 12,148 totalExercise: $6.92Exp: 2021-03-31→ Common Stock (6,060 underlying) - Sale
Common Stock
2015-05-12$61.50/sh−1,160$71,336→ 7,820 total
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.43 to $61.42, inclusive.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.44 to $61.52, inclusive.
- [F3]This option is fully vested and exercisable.
Documents
Issuer
Anacor Pharmaceuticals, Inc.
CIK 0001411158
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001411158
Filing Metadata
- Form type
- 4
- Filed
- May 13, 8:00 PM ET
- Accepted
- May 14, 9:12 PM ET
- Size
- 10.4 KB